| UniProt ID | B3GN2_HUMAN | |
|---|---|---|
| UniProt AC | Q9NY97 | |
| Protein Name | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 | |
| Gene Name | B3GNT2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 397 | |
| Subcellular Localization |
Golgi apparatus membrane Single-pass type II membrane protein . |
|
| Protein Description | Beta-1,3-N-acetylglucosaminyltransferase involved in the synthesis of poly-N-acetyllactosamine. Catalyzes the initiation and elongation of poly-N-acetyllactosamine chains. Shows a marked preference for Gal(beta1-4)Glc(NAc)-based acceptors. [PubMed: 9892646 Probably constitutes the main polylactosamine synthase.] | |
| Protein Sequence | MSVGRRRIKLLGILMMANVFIYFIMEVSKSSSQEKNGKGEVIIPKEKFWKISTPPEAYWNREQEKLNRQYNPILSMLTNQTGEAGRLSNISHLNYCEPDLRVTSVVTGFNNLPDRFKDFLLYLRCRNYSLLIDQPDKCAKKPFLLLAIKSLTPHFARRQAIRESWGQESNAGNQTVVRVFLLGQTPPEDNHPDLSDMLKFESEKHQDILMWNYRDTFFNLSLKEVLFLRWVSTSCPDTEFVFKGDDDVFVNTHHILNYLNSLSKTKAKDLFIGDVIHNAGPHRDKKLKYYIPEVVYSGLYPPYAGGGGFLYSGHLALRLYHITDQVHLYPIDDVYTGMCLQKLGLVPEKHKGFRTFDIEEKNKNNICSYVDLMLVHSRKPQEMIDIWSQLQSAHLKC | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 22 | Phosphorylation | MMANVFIYFIMEVSK HHHHHHHHHHHHHHH | 3.90 | 22817900 | |
| 28 | Phosphorylation | IYFIMEVSKSSSQEK HHHHHHHHHCCCCCC | 17.32 | - | |
| 45 | Ubiquitination | KGEVIIPKEKFWKIS CCEEEEEHHHHCCCC | 64.23 | 22817900 | |
| 46 (in isoform 2) | Ubiquitination | - | 48.40 | 21890473 | |
| 47 | Ubiquitination | EVIIPKEKFWKISTP EEEEEHHHHCCCCCC | 63.75 | 22817900 | |
| 50 | Ubiquitination | IPKEKFWKISTPPEA EEHHHHCCCCCCHHH | 29.88 | 21890473 | |
| 50 (in isoform 1) | Ubiquitination | - | 29.88 | 21890473 | |
| 50 | Ubiquitination | IPKEKFWKISTPPEA EEHHHHCCCCCCHHH | 29.88 | 21890473 | |
| 79 | N-linked_Glycosylation | PILSMLTNQTGEAGR HHHHHHHCCCCCCCC | 33.19 | 16335952 | |
| 89 | N-linked_Glycosylation | GEAGRLSNISHLNYC CCCCCCCCCCCCCCC | 44.36 | UniProtKB CARBOHYD | |
| 122 | Phosphorylation | RFKDFLLYLRCRNYS HHHHHHHHHHCCCCE | 8.34 | 23025827 | |
| 127 | N-linked_Glycosylation | LLYLRCRNYSLLIDQ HHHHHCCCCEEEECC | 34.08 | UniProtKB CARBOHYD | |
| 137 | Ubiquitination | LLIDQPDKCAKKPFL EEECCCHHHCCCCHH | 42.65 | - | |
| 173 | N-linked_Glycosylation | GQESNAGNQTVVRVF CCCCCCCCCEEEEEE | 31.75 | UniProtKB CARBOHYD | |
| 175 | Phosphorylation | ESNAGNQTVVRVFLL CCCCCCCEEEEEEEE | 25.60 | 24719451 | |
| 195 (in isoform 2) | Ubiquitination | - | 28.49 | 21890473 | |
| 199 | Ubiquitination | PDLSDMLKFESEKHQ CCHHHHHHHCCHHHC | 40.21 | 21906983 | |
| 199 (in isoform 1) | Ubiquitination | - | 40.21 | 21890473 | |
| 219 | N-linked_Glycosylation | NYRDTFFNLSLKEVL CCHHHCCCCCHHHHH | 25.24 | UniProtKB CARBOHYD | |
| 221 | Phosphorylation | RDTFFNLSLKEVLFL HHHCCCCCHHHHHHH | 38.20 | 24719451 | |
| 264 (in isoform 2) | Ubiquitination | - | 60.38 | 21890473 | |
| 264 | Ubiquitination | NYLNSLSKTKAKDLF HHHHHCCCCCCHHHC | 60.38 | - | |
| 268 | Ubiquitination | SLSKTKAKDLFIGDV HCCCCCCHHHCCCHH | 57.42 | 21906983 | |
| 268 (in isoform 1) | Ubiquitination | - | 57.42 | 21890473 | |
| 349 | Ubiquitination | KLGLVPEKHKGFRTF HHCCCCCCCCCCCCC | 44.54 | 27667366 | |
| 357 (in isoform 2) | Ubiquitination | - | 46.94 | 21890473 | |
| 361 (in isoform 1) | Ubiquitination | - | 61.50 | 21890473 | |
| 361 | Ubiquitination | RTFDIEEKNKNNICS CCCCCHHHCCCCCCH | 61.50 | 2190698 | |
| 368 | Phosphorylation | KNKNNICSYVDLMLV HCCCCCCHHHEEEHH | 25.13 | 22210691 | |
| 377 | Phosphorylation | VDLMLVHSRKPQEMI HEEEHHHCCCHHHHH | 34.22 | 22210691 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of B3GN2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of B3GN2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of B3GN2_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-79, AND MASS SPECTROMETRY. | |